Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Persistence with Antihypertensive Agents for 12 Months After Ischemic Stroke Reduces the Rates of Death and Dependency
First author：Jie Xu,Chunxue Wang
Corresponding author：Yongjun Wang
essential_information
- Person in charge：Jie Xu,Chunxue Wang
- Data Sources： CNSR-I
- Number of papers：CNSR120150025
- Published time：2012-12-26
2012-12-26
Published articles
Journal：CNS Neuroscience & Therapeutics
Publication type: Original Contributions
IF(IF): 5.243
PMID: 23279879 Link To Pubmed Full text Download
Background And Purpose
High adherence to antihypertensive therapy, and the associated blood pressure control, reduces the risk of initial stroke when used as primary prevention [1–3]. Kettani et al. [1] found that patients with high adherence to antihypertensive therapy (＞＝80% calcu-lated using the medication possession ratio) had a significantly lower risk of cerebrovascular disease, compared with patients with lower adherence. However, to our knowledge, the relationship between adherence to antihypertensive therapy after stroke and clinical outcomes has not been studied. The aim of this study was to assess the relationship between persistence with antihyperten-sive therapy after ischemic stroke and rates of death and depen-dency in patients with hypertension.